{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:58:48Z","timestamp":1785308328388,"version":"3.55.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":131,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cerebral radiation necrosis (RN) is a frequent adverse event of stereotactic radiotherapy (SRT) for brain metastases. This retrospective, single-center cohort study compares surgical resection with bevacizumab for the management of RN-associated cerebral edema in patients with brain metastases following SRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were extracted from the electronic health records of patients &amp;gt;18 years old that were operated or received bevacizumab for metastatic cerebral RN at Erasmus MC. Inclusion criteria were histopathologically confirmed or a clinical and radiological diagnosis of cerebral RN. Primary outcomes included dexamethasone usage, post-treatment edema volume, and adverse event rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 62 patients treated with resection and 32 with bevacizumab, both interventions resulted in significant reductions in cerebral edema and dexamethasone usage. Surgical resection resulted in a higher rate of dexamethasone discontinuation (81.0% vs 46.7%, P\u2009&amp;lt;\u2009.0001) and a lower incidence of grade 2 or higher adverse events (3.2% vs 43.8%) than bevacizumab. Overall survival did not differ between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Surgical resection can serve as a principal therapeutic strategy for RN-associated cerebral edema in appropriately selected cases where procedural risk is deemed acceptable. Prospective studies are warranted to refine criteria for patient selection and to optimize management strategies for RN occurring in the context of brain metastases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/noajnl\/vdag120","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:42:48Z","timestamp":1778240568000},"source":"Crossref","is-referenced-by-count":2,"title":["Surgical resection or bevacizumab for treatment of radiation necrosis-associated cerebral edema in patients with brain metastases: A single center experience"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5972-8517","authenticated-orcid":false,"given":"Miles E","family":"Dijkstra\u2020","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9266-2815","authenticated-orcid":false,"given":"Joost W","family":"Schouten\u2020","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Plegt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L","family":"Peulen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon","family":"van Hees","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7874-6253","authenticated-orcid":false,"given":"Cleo","family":"Slagter","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-7485","authenticated-orcid":false,"given":"Bibi L J","family":"Bouwen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-5127","authenticated-orcid":false,"given":"Martin J","family":"van den Bent","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-2755","authenticated-orcid":false,"given":"Joost L M","family":"Jongen","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3647-6740","authenticated-orcid":false,"given":"Eelke M","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2026052301460752500_vdag120-B1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"2026052301460752500_vdag120-B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"key":"2026052301460752500_vdag120-B3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/jco.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026052301460752500_vdag120-B4","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/neuonc\/not130","article-title":"Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases","volume":"15","author":"Leeman","year":"2013","journal-title":"Neuro Oncol"},{"key":"2026052301460752500_vdag120-B5","doi-asserted-by":"publisher","first-page":"794615","DOI":"10.3389\/fonc.2021.794615","article-title":"Volume of disease as a predictor for clinical outcomes in patients with melanoma brain metastases treated with stereotactic radiosurgery and immune checkpoint therapy","volume":"11","author":"Burke","year":"2021","journal-title":"Front Oncol"},{"key":"2026052301460752500_vdag120-B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17213542","article-title":"Radiation necrosis in neuro-oncology: diagnostic complexity and precision radiotherapy strategies","volume":"17","author":"Mittelman","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026052301460752500_vdag120-B7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijrobp.2009.06.006","article-title":"Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery","volume":"77","author":"Blonigen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026052301460752500_vdag120-B8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3857\/roj.2020.00171","article-title":"Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response","volume":"38","author":"Sayan","year":"2020","journal-title":"Radiat Oncol J"},{"key":"2026052301460752500_vdag120-B9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/neuonc\/noab046","article-title":"The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis","volume":"23","author":"Jessurun","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026052301460752500_vdag120-B10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026052301460752500_vdag120-B11","doi-asserted-by":"publisher","first-page":"723541","DOI":"10.1155\/2012\/723541","article-title":"The molecular biology of brain metastasis","volume":"2012","author":"Rahmathulla","year":"2012","journal-title":"J Oncol"},{"key":"2026052301460752500_vdag120-B12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11060-021-03790-y","article-title":"The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes","volume":"153","author":"Newman","year":"2021","journal-title":"J Neurooncol"},{"key":"2026052301460752500_vdag120-B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","article-title":"A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations","volume":"118","author":"Vellayappan","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026052301460752500_vdag120-B14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1006\/nimg.2002.1221","article-title":"A robust method for extraction and automatic segmentation of brain images","volume":"17","author":"Kovacevic","year":"2002","journal-title":"Neuroimage"},{"key":"2026052301460752500_vdag120-B15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/WCO.0b013e32833e5a5d","article-title":"Steroids in neurooncology: actions, indications, side-effects","volume":"23","author":"Roth","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"2026052301460752500_vdag120-B16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/neuonc\/noz172","article-title":"Risk factors for the development of epilepsy in patients with brain metastases","volume":"22","author":"Wolpert","year":"2020","journal-title":"Neuro Oncol"},{"key":"2026052301460752500_vdag120-B17","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1200\/JCO.2018.79.00062018\/10\/01","article-title":"Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non\u2013Small-Cell lung cancer","volume":"36","author":"Arbour","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026052301460752500_vdag120-B18","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1002\/hsr2.115","article-title":"Bevacizumab as a steroid-sparing agent during immunotherapy for melanoma brain metastases: a case series","volume":"2","author":"Banks","year":"2019","journal-title":"Health Sci Rep"},{"key":"2026052301460752500_vdag120-B19","doi-asserted-by":"publisher","first-page":"e254347-e254347","DOI":"10.1001\/jamanetworkopen.2025.4347","article-title":"Symptomatic necrosis with dual Immune-Checkpoint inhibition and radiosurgery for brain metastases","volume":"8","author":"Vaios","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026052301460752500_vdag120-B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2026.01.002","article-title":"Dynamic susceptibility contrast MRI-derived oxygen metabolism and perfusion metrics for distinguishing radiation necrosis from tumor progression in irradiated brain metastases","author":"Koldeweij","year":"2026","journal-title":"Diagn Interv Imaging"},{"key":"2026052301460752500_vdag120-B21","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.neurad.2025.101386","article-title":"Diagnostic value of centrally restricted diffusion in differentiating radiation necrosis from tumor progression in brain metastases: a single-center observational study","volume":"52","author":"Laigle","year":"2025","journal-title":"J Neuroradiol"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdag120\/68270406\/vdag120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag120\/68270406\/vdag120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag120\/68270406\/vdag120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:46:12Z","timestamp":1779515172000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdag120\/8676177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdag120","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"vdag120"}}